discoveried CXCL9/Mig can enhance T-cell recruitment in valvular tissue lesions, which is linked to the progression of ARF toward RHD (Brouwer et al., 2023; Faé et al., 2013). Here, CXCL9 is linked to rheumatic heart disease.